|
|
|
10.07.25 - 15:06
|
Incyte′s Q2 2025 Earnings: What to Expect (Barchart)
|
|
|
Incyte is gearing up to report its fiscal second-quarter earnings later this month, with analysts forecasting a sharp surge in profitability, projecting triple-digit year-over-year profit growth....
|
|
|
10.07.25 - 14:06
|
Incyte to Report Second Quarter Financial Results (Business Wire)
|
|
|
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 29, 2025.
The schedule for the press release and conference call/webcast is as follows:
Q2 2025 Press Release: July 29, 2025 at 7:00 a.m. ET
Q2 2025 Conference Call: July 29, 2025 at 8:00 a.m. ET
Domestic Dial-In Number: 877-407-3042
International Dial-In Number: 201-389-0864
Conference ID Number: 13754581
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13754581.
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find...
|
|
|
|
|
|
|
|
|
03.07.25 - 14:45
|
Incyte: Neuer CEO, neue Perspektive? (Sharedeals)
|
|
|
Das US-Pharmaunternehmen Incyte verzeichnet starkes Wachstum. Trotzdem kommt der Kurs noch nicht richtig zum Laufen. Ändert sich das jetzt durch einen CEO-Wechsel? Strategischer Neuanfang mit neuem CEO Die Incyte Corporation hat kürzlich einen bedeutenden Wechsel an der Unternehmensspitze bekannt gegeben. Mit Bill Meury übernimmt ein erfahrener Manager das Ruder, der bereits bei wachstumsstarken Unternehmen wie […]
The post Incyte: Neuer CEO, neue Perspektive? first appeared on sharedeals.de....
|
|
|
02.07.25 - 22:36
|
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
|
|
|
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today equity inducement awards grants to Bill Meury in connection with his appointment as the Company's new President and Chief Executive Officer. The awards are made pursuant to the Company's 2024 Inducement Stock Incentive Plan and were approved by the compensation committee of the Company's Board of Directors as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
As an inducement material to his employment and in lieu of the annual equity awards the Company typically grants in July of each year, Mr. Meury received, with a grant and vesting commencement date of June 26, 2025, an award of stock options to purchase 110,630 shares of the Company's common stock and, with a grant and vesting commencement date of July 2, 2025, an award of restricted stock units (RSUs) to acquire 36,101 shares of the Company's common stock and an award of perfor...
|
|
|
|
|
|
|
26.06.25 - 13:33
|
Incyte Appoints Bill Meury Chief Executive Officer; Hervé Hoppenot to Retire (Business Wire)
|
|
|
- Three-decade industry leader, former CEO of Karuna and Anthos and Chief Commercial Officer of Allergan, Bill Meury, joins Incyte as President and CEO
- Hervé Hoppenot to retire after 11 years of leading Incyte through major expansion
- Julian Baker elected Chairman of the Board of DirectorsWILMINGTON, Del.--(BUSINESS WIRE)--$INCY--Incyte (Nasdaq:INCY) today announced that the Company's Board of Directors has unanimously appointed Bill Meury as President and Chief Executive Officer (CEO) and a member of the Company's Board of Directors, effective immediately.
Bill Meury succeeds Hervé Hoppenot who will retire from the Company after 11 years of service. Mr. Hoppenot will serve as an advisor to the CEO and will remain as a member of the Board through the end of the year to ensure a smooth transition. In addition, Lead Independent Director Julian Baker has been elected Chairman of the Board of Directors.
Mr. Meury is a proven enterprise leader with expertise in organizational strategy, pipeline and comm...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
